Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 685 | 898 | 717 | 932 | 837 | 1116 |
Fund Return | -31.53% | -10.24% | -28.3% | -2.32% | -3.5% | 1.1% |
Place in category | 1250 | 832 | 1271 | 858 | 953 | 669 |
% in Category | 57 | 36 | 58 | 47 | 70 | 82 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
First Eagle Amundi Intl Fund Classr | 6.43B | 14.39 | 7.22 | 5.89 | ||
FirstEagleAmundiIntlClassAU2CShares | 6.43B | 9.65 | 4.00 | 5.17 | ||
First Eagle Amundi International Fq | 6.43B | 10.43 | 4.60 | 5.52 | ||
LU0068578508 | 6.42B | 9.64 | 3.87 | 4.98 | ||
First Eagle Amundi Intl Fund Classc | 6.43B | 10.84 | 5.00 | 6.08 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
GS S GS Europe CORE Equity Portfolu | 2.86B | 5.94 | 1.86 | 5.54 | ||
MFSM European Value Fund N1 USD | 2.3B | 1.25 | -1.50 | 4.92 | ||
MFSM European Value Fund A1 USD | 2.3B | -1.61 | -3.92 | 5.39 | ||
MFSM European Value Fund I1 USD | 2.3B | -0.81 | -3.03 | 6.42 | ||
MFSM European Value Fund W1 USD | 2.3B | -0.87 | -3.20 | 6.18 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 5.66 | 607.7 | -0.51% | |
AstraZeneca | GB0009895292 | 4.27 | 11,232.0 | +0.56% | |
Relx | GB00B2B0DG97 | 3.96 | 3,970.00 | +0.25% | |
Deutsche Boerse | DE0005810055 | 3.84 | 237.8000 | -0.29% | |
Schneider Electric | FR0000121972 | 3.84 | 237.45 | +4.74% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Sell | Strong Sell |
Technical Indicators | Strong Buy | Strong Sell | Strong Sell |
Summary | Buy | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review